… study was to compare the efficacy of gefitinib and erlotinib in … compares gefitinib and
erlotinib treatment, not to mention a study … In the present study, we retrospectively evaluated the …

… study were as follows: histologically confirmed NSCLC, age 20 years or over, relapsed after
gefitinib treatment … prior gefitinib therapy to specify treatment effects of erlotinib after failure of …

… study was to identify predictive factors for erlotinib treatment … In the present study, we found
that the PFS of prior gefitinib is … for the clinical efficacy of erlotinib following gefitinib failure. A …

… randomized studies that investigated erlotinib or gefitinib in … phase II study of single-agent
erlotinib as first-line therapy in … studies on tumor samples of patients entered in the study to …

… , erlotinib or gefitinib. The purpose of this study was to assess efficacies of erlotinib and gefitinib
… The comparison of erlotinib and gefitinib in treatment of LMC from NSCLC has not been …

… This study showed that erlotinib significantly prolonged … of erlotinib single-agent therapy
in recurrent GBM [38]. In colorectal cancer, single-agent treatment with TKIs (erlotinib, gefitinib) …

… No relevant systematic reviews that answered our research questions were identified. …
The os with gefitinib therapy trended longer in the mutation-positive subgroup (hr: 0.78; 95% ci: …

… Study design and patients Patients were eligible for this study if they had stage IV NSCLC or
… mutations and were treated with gefitinib, erlotinib, or chemotherapy as their initial systemic …

… in patients treated with gefitinib or erlotinib varied substantially among trials. In a phase II study
… Our search yielded a total of 496 potentially relevant studies with gefitinib or erlotinib. The …

… Afatinib and gefitinib have also demonstrated efficacy in the first-line … our study was that
specific combinations of post-study therapy were not documented, eg maintenance erlotinib plus …